Evidence map›Paper›PMID 33572639›Full record

ArticleVaccines2021

Elderly Subjects Supplemented with L-Glutamine Shows an Improvement of Mucosal Immunity in the Upper Airways in Response to Influenza Virus Vaccination.

Vitória Paixão, Ewin B Almeida, Jonatas B Amaral, Tamaris Roseira, Fernanda R Monteiro, Roberta Foster, Adriane Sperandio, Marcelo Rossi, Gislene R Amirato, Carlos A F Santos and 8 more

Open access · goldAbstract read
In one paragraph

Article in Vaccines, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 16 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Mining Anti-Inflammation Molecules FromFrontiers in cellular and infection microbiology · 2021
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 1 country.

Vitória PaixãoDepartment of Otorhinolaryngology, ENT Lab, Federal University of São Paulo (UNIFESP), São Paulo 04021-001, Brazil.ORCID 0000-0002-3537-4606
Ewin B AlmeidaDepartment of Otorhinolaryngology, ENT Lab, Federal University of São Paulo (UNIFESP), São Paulo 04021-001, Brazil.
Jonatas B AmaralDepartment of Otorhinolaryngology, ENT Lab, Federal University of São Paulo (UNIFESP), São Paulo 04021-001, Brazil.ORCID 0000-0001-5819-0474
Tamaris RoseiraDepartment of Otorhinolaryngology, ENT Lab, Federal University of São Paulo (UNIFESP), São Paulo 04021-001, Brazil.ORCID 0000-0002-1784-0490
Fernanda R MonteiroDepartment of Otorhinolaryngology, ENT Lab, Federal University of São Paulo (UNIFESP), São Paulo 04021-001, Brazil.
Roberta FosterDepartment of Otorhinolaryngology, ENT Lab, Federal University of São Paulo (UNIFESP), São Paulo 04021-001, Brazil.
Adriane SperandioMethod Faculty of São Paulo (FAMESP), São Paulo 04046-200, Brazil.
Marcelo RossiDepartment of Otorhinolaryngology, ENT Lab, Federal University of São Paulo (UNIFESP), São Paulo 04021-001, Brazil.
Gislene R AmiratoDepartment of Otorhinolaryngology, ENT Lab, Federal University of São Paulo (UNIFESP), São Paulo 04021-001, Brazil.
Carlos A F SantosDepartment of Medicine, Geriatry, Paulista School of Medicine (EPM), São Paulo 04023-062, Brazil.
Renier S PiresPost-Graduation Program in Health Science, Santo Amaro University (UNISA), São Paulo 04743-030, Brazil.
Fabyano B LealInstitute of Biomedical Science, University of São Paulo (USP), São Paulo 05508-060, Brazil.
Edison L DurigonInstitute of Biomedical Science, University of São Paulo (USP), São Paulo 05508-060, Brazil.
Danielle B L OliveiraInstitute of Biomedical Science, University of São Paulo (USP), São Paulo 05508-060, Brazil.ORCID 0000-0002-0534-0886
Rodolfo P VieiraBrazilian Institute of Teaching and Research in Pulmonary and Exercise Immunology (IBEPIPE), São Paulo 12245-520, Brazil.ORCID 0000-0001-6379-1143
Mauro VaisbergDepartment of Otorhinolaryngology, ENT Lab, Federal University of São Paulo (UNIFESP), São Paulo 04021-001, Brazil.ORCID 0000-0003-0292-3792
Juliana M B SantosPost-Graduation Program in Science of Human and Rehabilitation, Federal University of São Paulo (UNIFESP), Santos 11015-020, Brazil.ORCID 0000-0003-0527-0723
André L L BachiDepartment of Otorhinolaryngology, ENT Lab, Federal University of São Paulo (UNIFESP), São Paulo 04021-001, Brazil.ORCID 0000-0001-8266-1416
Universidade Federal de São Paulo · BRUniversidade de São Paulo · BRUniversidade de Santo Amaro · BRAssociação Paulista de Medicina · BRUniversidade Brasil · BR

Funding

Fundação de Amparo à Pesquisa do Estado de São Paulo 2010/50025-1, 2012/15165-2, 2019/14115-0, 2019/13094-0 and 2019/13188-4
6 · The paper itself

Abstract

backgroundAlthough glutamine is able to improve the immune response, its action in the upper airway immunity against the influenza virus vaccine remains unclear. Therefore, we aimed to evaluate the L-glutamine supplementation effect on the mucosal immune/inflammatory response of elderly subjects vaccinated against the influenza virus.

methodsSaliva sampling from 83 physically active elderly volunteers were collected pre- and 30 days after influenza virus vaccination and supplementation with L-glutamine (Gln,

resultsGln group showed higher salivary levels of interleukin (IL)-17, total secretory immunoglobulin A (SIgA), and specific-SIgA post-vaccination than values found pre-vaccination and in the PL group post-vaccination. Whereas higher salivary levels of IL-6 and IL-10 were observed post-vaccination in the Gln group, IL-37 levels were lower post-vaccination in both groups than the values pre-vaccination. Tumor necrosis factor (TNF)-α levels were unchanged. Positive correlations between IL-6 and IL-10 were found in all volunteer groups pre- and post-vaccination and also between IL-17 and IL-6 or IL-10 in the Gln group post-vaccination. A negative correlation between IL-37 and IL-10 was found pre- and post-vaccination in the PL group.

conclusionGln supplementation was able to modulate salivary cytokine profile and increase SIgA levels, both total and specific to the influenza virus vaccine, in physically active elderly subjects.

Indexed as

antibodiescytokinesimmunoglobulininfluenza virusL-glutaminevaccine

Identifiers

PMID33572639
PMCPMC7911866
OpenAlexW3129052561

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.